Tennessee Oncology, PLLC — Nashville, Tennessee

Public research footprint of Tennessee Oncology, PLLC, compiled from the ClinicalTrials.gov public registry.

384

Registered studies

Active

Recruiting now

226

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer Metastatic · Prostate Cancer · Carcinoma, Non-Small-Cell Lung · Breast Cancer

Recently updated registry entries

NCT06982521 — Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for… (Recruiting)
NCT06465069 — A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or… (Recruiting)
NCT06623422 — A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Tennessee Oncology, PLLC?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.